Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Opsens Inc T.OPS

Alternate Symbol(s):  OPSSF

OpSens Inc focuses on interventional cardiology, offering an advanced optical-based pressure guidewire which aims at improving the clinical outcome of patients with coronary artery disease. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and excellent lesions access. The OptoWire has been used in the diagnosis and treatment of over 100,000 patients in more than 30 countries. It is approved for sale...

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 
@ the Bell: Markets start second half of '22 trading on upbeat note
Canada’s resources-heavy stock index rose on Monday as oil prices gained and investors returned from a long weekend to purchase riskier assets that have been battered by concerns over a global... read article.

RE:As much as I would like to see

In the past 3 months: TSX is 15% under Dow Jones 10% under NASDAQ 22% under Opsen in the last 3 monts rose 42% It feels like your technical anaysis is very flawed. Good luck to shorts!  rate and reply

Who is FormTex?

Newly acquired by Good Natured for USD $4.8M, FormTex generated unaudited revenue of USD $5.1M for the trailing twelve months ended February 28, 2022, and an unaudited gross margin rate of approximately 42% in FY2021. Through this acquisition, GDNP now has strategic access to Texas and the Southern US. and will be able to leverage Houston-based manufacturing, importing, warehousing, and logistics to service the southeastern U.S. market, including Florida, Georgia, and North Carolina. more

As much as I would like to see

this stock perform better than it has this year, my technicals are saying otherwise at the moment.  Without getting too much into the details, OPS has had more than enough time to breakout of more

RE:Canadian markets closed but…

Not likely imo. Just somebody who wants to buy some , going to the only place they can get shares,  and since there's a limited quantity they have to pay more.  rate and reply

Canadian markets closed but…

On the OTCQX International Opsens is up 6.5% or 11 cents US. Could something be brewing? GLTA  rate and reply
The Market Herald's Weekly Cannabis Report
Affinor Growers (CSE:AFI) announces $2 million private placementSource: Affinor Growers Inc.Affinor Growers Inc. (CSE.AFI, OTCQB: RSSFF, Forum) is undertaking a private placeme... read article.
Buzz on the Bullboards: Sizzling sector highlights
It has been a sizzling few days recently for most of North America, both weather-wise and for investing discussions. The markets face a rate hike in the U.S., ongoing inflation, rising oil and... read article.

RE:Good day!

Nice breakout these past few days . GLTA.  rate and reply

Top Gainers

Symbol/ Company Price $ Change $ Volume Data delayed at least 15 minutes, as of 27/06/2022 12:11 PM ET | All market data delayed more

RE:Good day!

Definitely Morgan Stanley pumping it up. I would love to know what the strategy is. Last record high was MS buying and they were selling on the way down as well.  rate and reply

Good day!

Anonymous and Morgan Stanley have switched on the Buying side! Better volume than the last weeks and a good increase. Q3 results in 2 -3 weeks. It smells good! GLTA!  rate and reply

We need more positive comments...

 TAVR procedure benefits a larger group of patients and with the minimalist approach growing in popularity within the medical community, the benefits of the SavvyWire could be significant." more

RE:RE:Its a marvelous day!

Last this, If I’m not wrong Mr. Villeneuve only Have 25k options to exercise at 1.33.  rate and reply

Top Gainers

Pretty impressive during another tough day in the markets. GLTA Symbol/ Company Price $ Change $ Volume Data delayed at least 15 minutes, more

RE:Its a marvelous day!

Robin Villeneuve exercised options without selling any this Week. Robin Villeneuve did many transactions since one month or more. Exercised ar 1.33 And sold on open market right after. But not more

Its a marvelous day!

Hopefully we finish with a bang!  rate and reply

RE:first commercial use Savvywire (TM)

The Fall is shaping up to be transformational for us . GLTA   rate and reply

RE:RE:RE:TAVR procedure potential...

Here's the press release dating back to September 3rd 2015 relating to the corporate restructuring I was referring to in my previous post: more

RE:RE:TAVR procedure potential...

Dogs, either you're short and a bit worried so you try to keep the stock down or you didn't do your research properly ...or both. Opsens reorganised in 2015 to seperate physically more

RE:TAVR procedure potential...

Edwards Lifescience per example could be interested in Opsens Medical but couldn't care less about Opsens Solutions which is why I doubt Opsens the company will be a take over target.   rate and reply

TAVR procedure potential...

Opsens to be a take over target not long after FDA approval... The TAVR procedure is on the rise, driven by an aging of the population and recent studies that demonstrate its benefits to patients more

may 7 th $1.74 june 7 $2.26

The last month was very tough for investors but in the same period Opsens is up 30%. In about 5 weeks the results of the third quarter will come out and i  think those will be very good. glta  rate and reply

RE:first commercial use Savvywire (TM)

FDA approval is now expected in the Fall. Initially they had said late Summer or Fall.  rate and reply